EFFECT OF SULPIRIDE ON CHRONIC ABSTINENCE SYNDROME IN ADDICTED PATIENTS

被引：7

作者：

PATTI, F

DRAGO, F

MARANO, P

NICOLETTI, F

SCAPAGNINI, U

机构：

[1] UNIV CATANIA,FAC MED,SCH MED,INST PHARMACOL,VIALE A DORIA 6,I-95125 CATANIA,ITALY

[2] UNIV CATANIA,SCH MED,INST NEUROL,I-95125 CATANIA,ITALY

来源：

CLINICAL NEUROPHARMACOLOGY | 1986年 / 9卷 / 05期

关键词：

D O I：

10.1097/00002826-198610000-00008

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：469 / 476

页数：8

共 29 条

[1]

Agnoli A., 1980, CENTRAL PERIPHERAL R, P347

[2]

BENAKIS A, 1976, EUR J DRUG METAB PHA, V51, P1

[3]

CHARLESNICOLAS AJ, 1974, VIE MED, V34, P4223

[4] NEURO-PHARMACOLOGICAL STUDIES ON THE NEUROLEPTIC POTENTIAL OF DOMPERIDONE (R33812) [J].

COSTALL, B ;

FORTUNE, DH ;

NAYLOR, RJ .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1979, 31 (05) :344-347

[5]

DEMAIO D, 1979, SULPIRIDE OTHER BENZ, P283

[6] EFFECTS OF HALOPERIDOL ON MORPHINE-INDUCED ANTINOCICEPTION MORPHINE-TOLERANCE AND WITHDRAWAL IN HYPERPROLACTINEMIC RATS [J].

DRAGO, F ;

KOVACS, GL ;

SZABO, G ;

SCAPAGNINI, U ;

TELEGDY, G .

NEUROPHARMACOLOGY, 1985, 24 (11) :1027-1031

[7] EFFECTS OF ENDOGENOUS HYPERPROLACTINEMIA ON OPIATE-INDUCED BEHAVIORAL-CHANGES IN RATS [J].

DRAGO, F ;

SCAPAGNINI, U .

BRAIN RESEARCH, 1985, 336 (02) :215-221

[8]

DRAGO F, 1984, FRONTIERS NEUROSCIEN, P137

[9]

DRAGO F, 1981, ADV ENDOGENOUS EXOGE, P335

[10]

GOLD MS, 1978, LANCET, V2, P599

← 1 2 3 →